2Stohrer M, Goepel M, Kondo A, et al. The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee[J].Neurourol Urodyn, 1999, 18(2): 139-158.
7Ay A, Demir A, Kismet K, et al. Idiopathic giant atonic bladder (6000 mL in volume) that is present for 15 years with no urinary symptoms[J].Canad Urol Assoc J, 2013, 7(1-2):135-137.
8Samson G, Cardenas D. Neurogenic bladder in spinal cord injury[J].Phys Med Rehabil Clin N Am, 2007, 18(2): 255-274.
9Kramer G, Meyerhof D. The Canadian National Calibration Reference Centre for In-Vivo Monitoring: thyroid monitoring. Part V: Minimizing placement error in a thyroid monitoring system[J].Can J Med Radiat Technol, 1994, 25(4): 125-128.
10Abrams P, Andersson K E, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence[J].Neurourol Urod, 2010, 29(1): 213-240.
5Madershaeher H, Wyndaele JJ,Igawa Y,et al. Conservative management in neuropatie urinary incontinence[M]. In: Inconti- nence, 2nd ed. Abrams P, Khoury S, Wein A, eds. Plymoulh, Health Publication, 2002, 697--754.
6Greenfield SP,Fera M. The use of intravesical oxybulynin chlo- ride in children with neurogenie bladder[J]. J Uro1(S0022- 5347), 1991, 146: 532-534.
7Das A, Chancellor MB, Watanabe T, et al. Intravesieal eapsa- iein in neurologie impaired patients with detrusor hyperreflexia [J]. J Spinal Cord Med(S1079-0268), 1996, 19: 190-193.
8Chancelle MB, Groat WC. Intravesical Capsaicin and resinifer- atoxin therapy: spicing up the ways that we treat lhe everac- tive bladder[J]. J Uro1(S0022-5347), 1999, 162: 3-11.
9Schurch B, Stohrer M, Kramer G, et al. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured pa- tients: a new alternative to anticholinergic drugs? Preliminary Results[J]. J Uro1(S0022-5347), 2000, 164: 692-697.
10Karsenty G, Denys P, Amareneo G, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detru- sor overactivity/neurogenic overactive bladder: a systematic lit- eratulure rcview[J]. Eur Urol, 2008, 53(2): 275-287.
